Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

radiobiology/dosimetry

  • MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
    You have access
    MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
    Sumudu Katugampola, Jianchao Wang and Roger W. Howell
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1965-1973; DOI: https://doi.org/10.2967/jnumed.123.267238
  • Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
    Open Access
    Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
    Allen F. Brooks, Wade P. Winton, Jenelle Stauff, Janna Arteaga, Bradford Henderson, Jeremy Niedbala, Peter J.H. Scott and Benjamin L. Viglianti
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1949-1955; DOI: https://doi.org/10.2967/jnumed.122.263864
  • You have access
    RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
    Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034
  • You have access
    RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 1—Collection of Data for Radiopharmaceutical Dosimetry
    Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 316-322; DOI: https://doi.org/10.2967/jnumed.120.259200
  • You have access
    Characterization of Noise and Resolution for Quantitative 177Lu SPECT/CT with xSPECT Quant
    Johannes Tran-Gia and Michael Lassmann
    Journal of Nuclear Medicine January 1, 2019, 60 (1) 50-59; DOI: https://doi.org/10.2967/jnumed.118.211094
  • You have access
    90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
    Yusuf Menda, Mark T. Madsen, Thomas M. O’Dorisio, John J. Sunderland, G. Leonard Watkins, Joseph S. Dillon, Sarah L. Mott, Michael K. Schultz, Gideon K.D. Zamba, David L. Bushnell and M. Sue O’Dorisio
    Journal of Nuclear Medicine November 1, 2018, 59 (11) 1692-1698; DOI: https://doi.org/10.2967/jnumed.117.202903
  • You have access
    New Fetal Radiation Doses for 18F-FDG Based on Human Data
    Paolo Zanotti-Fregonara and Michael G. Stabin
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1865-1866; DOI: https://doi.org/10.2967/jnumed.117.195404
  • You have access
    New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms
    Paolo Zanotti-Fregonara, Mathieu Chastan, Agathe Edet-Sanson, Ozgul Ekmekcioglu, Ezgi Basak Erdogan, Sebastien Hapdey, Elif Hindie and Michael G. Stabin
    Journal of Nuclear Medicine November 1, 2016, 57 (11) 1760-1763; DOI: https://doi.org/10.2967/jnumed.116.173294
  • You have access
    Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
    Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson and Monica Shokeen
    Journal of Nuclear Medicine April 1, 2016, 57 (4) 640-645; DOI: https://doi.org/10.2967/jnumed.115.164624
  • You have access
    MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy
    Michael Ljungberg, Anna Celler, Mark W. Konijnenberg, Keith F. Eckerman, Yuni K. Dewaraja and Katarina Sjögreen-Gleisner
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 151-162; DOI: https://doi.org/10.2967/jnumed.115.159012
SNMMI

© 2025 SNMMI

Powered by HighWire